Literature DB >> 15262199

Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.

Li Ma1, Louise F B Nicholson.   

Abstract

The accumulation of amyloid-beta and increased expression of its receptor RAGE (the receptor for advanced glycation end products) have been implicated in the pathogenesis of Alzheimer's disease (AD). Here we have used immunohistochemistry and double labelling to localize RAGE expression in Huntington's disease (HD) caudate nucleus (CN). Results showed that RAGE is expressed in at least two cell types in the CN, medium spiny projection neurons and astrocytes, with stronger staining in astrocytes than in neurons. The percentage of the total number of neurons positive for RAGE was significantly higher in G2 and G3 HD CN when compared with controls. What is more interesting however was the heterogeneous distribution of RAGE staining in CN. In controls, astrocytic RAGE staining was seen only in the superficial layer of the subependymal layer (SEL). In G1 HD cases, staining was seen throughout the entire width of SEL but extended into the CN in G2, 3 and 4. Neuronal RAGE staining was stronger in the medial CN than in the lateral CN in control and G1 cases. In G2, 3 and 4 cases, this staining gradient was not observed; more neuronal RAGE staining was however seen in the dorsal part of the CN when compared with the ventral part. The distribution of RAGE staining in neurons appeared to correlate with the ordered cell death seen in HD CN. Identification of the ligand for RAGE in HD brain and further functional studies are needed to clarify the role of RAGE in the pathogenesis of HD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262199     DOI: 10.1016/j.brainres.2004.05.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Optimization of the Tet-On system for inducible expression of RAGE.

Authors:  Shamim Shaikh; Louise F B Nicholson
Journal:  J Biomol Tech       Date:  2006-09

2.  The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma.

Authors:  Noriko Himori; Hiroshi Kunikata; Yukihiro Shiga; Kazuko Omodaka; Kazuichi Maruyama; Hidetoshi Takahashi; Toru Nakazawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-30       Impact factor: 3.117

Review 3.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

4.  Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head.

Authors:  Gülgün Tezel; Cheng Luo; Xiangjun Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

5.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Patrick B Reeves; Jonathan Alexander; Kwadwo A Ansong; Nicholas Masso; Matthew P Frosch; Kimberly B Kegel; Xueyi Li; Marian DiFiglia
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

6.  Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.

Authors:  Michelle Y Wang; Fred N Ross-Cisneros; Divya Aggarwal; Chiao-Ying Liang; Alfredo A Sadun
Journal:  Acta Neuropathol       Date:  2009-03-11       Impact factor: 17.088

7.  RAGE gene polymorphisms in patients with multiple sclerosis.

Authors:  Zoltán Tiszlavicz; Zsofia Gyulai; Krisztina Bencsik; Zoltán Szolnoki; Agnes Katalin Kocsis; Ferenc Somogyvári; László Vécsei; Yvette Mándi
Journal:  J Mol Neurosci       Date:  2009-11       Impact factor: 3.444

Review 8.  Protein truncation as a common denominator of human neurodegenerative foldopathies.

Authors:  Santosh Jadhav; Norbert Zilka; Michal Novak
Journal:  Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.590

9.  Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis.

Authors:  Judyta K Juranek; Gurdip K Daffu; Joanna Wojtkiewicz; David Lacomis; Julia Kofler; Ann Marie Schmidt
Journal:  Front Cell Neurosci       Date:  2015-12-22       Impact factor: 5.505

10.  Neuronal cell death and regeneration in diseases associated with advanced glycation end-products accumulation.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Shuichi Yamamoto
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.